The Risk of Acute Radiocontrast-Mediated Kidney Injury Following Endovascular Therapy for Acute Ischemic Stroke Is Low

References

1. 1.↵
   1. del Zoppo GJ,
   2. Higashida RT,
   3. Furlan AJ,
   4. et al

   . PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke: PROACT Investigators—Prolyse in Acute Cerebral Thromboembolism. Stroke 1998; 29: 4– 11

   Abstract/FREE Full Text
2. 2.↵
   1. Furlan A,
   2. Higashida R,
   3. Wechsler L,
   4. et al

   . Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study—a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999; 282: 2003– 11

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Gobin YP,
   2. Starkman S,
   3. Duckwiler GR,
   4. et al

   . MERCI 1: a phase 1 study of Mechanical Embolus Removal in Cerebral Ischemia. Stroke 2004; 35: 2848– 54

   Abstract/FREE Full Text
4. 4.↵
   1. Smith WS,
   2. Sung G,
   3. Starkman S,
   4. et al.

   , for the MERCI Trial Investigators. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005; 36: 1432– 38

   Abstract/FREE Full Text
5. 5.↵
   The Penumbra Pivotal Stroke Trial Investigators. The Penumbra Pivotal Stroke Trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009; 40: 2761– 68. Epub 2009 Jul 9

   Abstract/FREE Full Text
6. 6.↵
   1. Kurnik BR,
   2. Allgren RL,
   3. Genter FC,
   4. et al

   . Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. Am J Kidney Dis 1998; 31: 674– 80

   PubMedWeb of Science
7. 7.↵
   1. Margulies KB,
   2. McKinley LJ,
   3. Cavero PG,
   4. et al

   . Induction and prevention of radiocontrast-induced nephropathy in dogs with heart failure. Kidney Int 1990; 38: 1101– 08

   PubMedWeb of Science
8. 8.↵
   1. Heyman SN,
   2. Reichman J,
   3. Brezis M.

   . Pathophysiology of radiocontrast nephropathy: a role for medullary hypoxia. Invest Radiol 1999; 34: 685– 91

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Nash K,
   2. Hafeez A,
   3. Hou S.

   . Hospital-acquired renal insufficiency. Am J Kidney Dis 2002; 39: 930– 36

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Bartholomew BA,
    2. Harjai KJ,
    3. Dukkipati S,
    4. et al

    . Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 2004; 93: 1515– 9

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Rich MW,
    2. Crecelius CA

    . Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older: a prospective study. Arch Intern Med 1990; 150: 1237– 42

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Maeder M,
    2. Klein M,
    3. Fehr T,
    4. et al

    . Contrast nephropathy: review focusing on prevention. J Am Coll Cardiol 2004; 44: 1763– 71

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Longstreth WT Jr.,
    2. Bernick C,
    3. Fitzpatrick A,
    4. et al

    . Frequency and predictors of stroke death in 5,888 participants in the Cardiovascular Health Study. Neurology 2001; 56: 368– 75

    Abstract/FREE Full Text
14. 14.↵
    1. Mehta RL,
    2. Kellum JA,
    3. Shah SV,
    4. et al.

    , for the Acute Kidney Injury Network. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11: R31

    CrossRefPubMed
15. 15.↵
    1. Wickenbrock I,
    2. Perings C,
    3. Maagh P,
    4. et al

    . Contrast medium induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome: differences in STEMI and NSTEMI. Clin Res Cardiol 2009; 98: 765– 72. Epub 2009 Oct 23

    CrossRefPubMed
16. 16.↵
    1. Jabara R,
    2. Gadesam RR,
    3. Pendyala LK,
    4. et al

    . Impact of the definition utilized on the rate of contrast-induced nephropathy in percutaneous coronary intervention. Am J Cardiol 2009; 103: 1657– 62

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Marenzi G,
    2. Assanelli E,
    3. Campodonico J,
    4. et al

    . Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality. Ann Intern Med 2009; 150: 170– 77

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Rudnick MR,
    2. Goldfarb S,
    3. Wexler L,
    4. et al

    . Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial—the Iohexol Cooperative Study. Kidney Int 1995; 47: 254– 61

    CrossRefPubMedWeb of Science
19. 19.↵
    1. McCullough PA,
    2. Wolyn R,
    3. Rocher LL,
    4. et al

    . Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 1997; 103: 368– 75

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Marenzi G,
    2. Lauri G,
    3. Assanelli E,
    4. et al

    . Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2004; 44: 1780– 85

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Rodriguez GJ,
    2. Cordina SM,
    3. Vazquez G,
    4. et al

    . The hydration influence on the risk of stroke (THIRST) study. Neurocrit Care 2009; 10: 187– 94. Epub 2008 Dec 3

    CrossRefPubMed
22. 22.↵
    1. Yoshida S,
    2. Kamihata H,
    3. Nakamura S,
    4. et al

    . Prevention of contrast-induced nephropathy by chronic pravastatin treatment in patients with cardiovascular disease and renal insufficiency. J Cardiol 2009; 54: 192– 98

    CrossRefPubMedWeb of Science
23. 23.↵
    ACT Trial Investigators. Rationale, design, and baseline characteristics of the Acetylcystein for Contrast-induced nephropaThy (ACT) Trial: a pragmatic randomized controlled trial to evaluate the efficacy of acetylcysteine for the prevention of contrast-induced nephropathy. Trials 2009; 10: 38
24. 24.↵
    1. Marenzi G,
    2. Assanelli E,
    3. Marana I,
    4. et al

    . N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med 2006; 354: 2773– 82

    CrossRefPubMedWeb of Science
25. 25.↵
    1. Barrett BJ,
    2. Parfrey PS

    . Clinical practice: preventing nephropathy induced by contrast medium. N Engl J Med 2006; 354: 379– 86

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Smith WS,
    2. Sung G,
    3. Saver JL,
    4. et al.

    , for the Multi MERCI investigators. Mechanical thrombectomy for acute ischemic stroke: final results of the multi MERCI trial. Stroke 2008; 39: 1205– 12

    Abstract/FREE Full Text